Home Page - 2026 Updates in Hematology & Oncology, Fresno

This CME-accredited oncology conference, 2026 Updates in Hematology & Oncology, Fresno, is designed to help oncology professionals integrate the latest scientific advances into clinical practice. Led by national and regional experts, this interactive symposium will translate practice-changing data from leading oncology conferences and peer-reviewed journals into actionable strategies for improving cancer care.

Participants will explore emerging biomarkers, gene signatures, and novel therapeutic agents that are reshaping treatment paradigms in hematologic malignancies and solid tumors. Sessions will focus on guideline-based management, patient-centered care, and effective communication strategies for introducing new therapies.

Through a blend of didactic lectures, case-based discussions, and live Q&A, attendees will gain practical insights to develop, evaluate, and apply evidence-based management plans grounded in the latest research, expert consensus, and updated clinical guidelines. This activity fosters lifelong learning, enhances clinical competence, and promotes optimal outcomes for patients with cancer.

Binaytara is a leading global oncology 501(c)(3) nonprofit, dedicated to reducing cancer health disparities around the world. Founded in 2007 by Tara Shah and Dr. Binay Shah, our mission is to improve access to cancer care, enhance continuing medical education (CME), and foster implementation science research in hematology and oncology, thereby reducing the global burden of cancer.

As the largest cancer conference organizer in the US, we impact thousands of doctors and oncology/hematology practitioners who attend our conferences to stay current on cutting-edge treatments for their patients. Binaytara is an accredited CME provider committed to improving patient outcomes through high-quality, independent CME activities for physicians, pharmacists, and nurses.

As a leader in global oncology, we have partnered with local government and health organizations in Nepal to operate the only cancer hospital in Madhesh Province, deliver cervical cancer screenings, provide nurse training, and establish the first bone marrow transplant center in the country. In India, we have partnered with government institutions to establish hospice and palliative care programs in Madhya Pradesh. We are beginning construction in 2024 on a comprehensive 200-bed cancer center in Janakpur, Nepal that will dramatically improve access to cancer care in Nepal and surrounding communities.

We invite companies interested in improving equitable access to cancer care to support our efforts.

DoubleTree by Hilton Hotel Fresno Convention Center